Press Release
Intended for Media and Investors
Navicixizumab Phase 1b data presented in Journal of Clinical Oncology
Mereo BioPharma's partner for the development of Navicixizumab, OncXerna Therapeutics Inc. announced that Navicixizumab Phase 1b data has been published in the Journal of Clinical Oncology.